Cardinal Health (CAH) Position Lifted by Flinton Capital Management LLC

Flinton Capital Management LLC boosted its holdings in shares of Cardinal Health (NYSE:CAH) by 41.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 63,216 shares of the company’s stock after buying an additional 18,592 shares during the period. Flinton Capital Management LLC’s holdings in Cardinal Health were worth $3,962,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also bought and sold shares of CAH. American International Group Inc. raised its position in Cardinal Health by 5,859.3% during the fourth quarter. American International Group Inc. now owns 7,969,384 shares of the company’s stock valued at $488,284,000 after buying an additional 7,835,654 shares during the period. BlackRock Inc. raised its position in Cardinal Health by 15.0% during the fourth quarter. BlackRock Inc. now owns 24,845,043 shares of the company’s stock valued at $1,522,257,000 after buying an additional 3,235,076 shares during the period. Boston Partners raised its position in Cardinal Health by 74.4% during the first quarter. Boston Partners now owns 6,095,384 shares of the company’s stock valued at $382,059,000 after buying an additional 2,599,918 shares during the period. Amundi Pioneer Asset Management Inc. acquired a new position in Cardinal Health during the fourth quarter valued at $111,944,000. Finally, Bank of New York Mellon Corp raised its position in Cardinal Health by 31.3% during the fourth quarter. Bank of New York Mellon Corp now owns 5,049,224 shares of the company’s stock valued at $309,366,000 after buying an additional 1,203,015 shares during the period. 91.69% of the stock is currently owned by hedge funds and other institutional investors.

A number of research analysts have commented on CAH shares. Royal Bank of Canada set a $83.00 target price on Cardinal Health and gave the company a “hold” rating in a research note on Thursday, February 8th. ValuEngine downgraded Cardinal Health from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Zacks Investment Research downgraded Cardinal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, April 17th. Jefferies Group set a $55.00 target price on Cardinal Health and gave the company a “hold” rating in a research note on Friday, May 4th. Finally, Mizuho set a $61.00 target price on Cardinal Health and gave the company a “hold” rating in a research note on Monday, May 7th. Five research analysts have rated the stock with a sell rating, nine have issued a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $70.33.

CAH opened at $52.44 on Monday. The stock has a market cap of $16.29 billion, a PE ratio of 9.71, a P/E/G ratio of 1.32 and a beta of 1.06. Cardinal Health has a 52-week low of $50.79 and a 52-week high of $80.37. The company has a quick ratio of 0.54, a current ratio of 1.10 and a debt-to-equity ratio of 1.20.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, May 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.51 by ($0.12). The company had revenue of $33.63 billion for the quarter, compared to the consensus estimate of $33.61 billion. Cardinal Health had a return on equity of 23.39% and a net margin of 1.26%. equities research analysts forecast that Cardinal Health will post 4.91 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Sunday, July 15th. Stockholders of record on Monday, July 2nd will be paid a dividend of $0.476 per share. This represents a $1.90 annualized dividend and a dividend yield of 3.63%. The ex-dividend date is Friday, June 29th. This is an increase from Cardinal Health’s previous quarterly dividend of $0.46. Cardinal Health’s dividend payout ratio is 34.26%.

Cardinal Health announced that its board has initiated a stock repurchase program on Thursday, February 8th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board believes its stock is undervalued.

About Cardinal Health

Cardinal Health, Inc operates as an integrated healthcare services and products company worldwide. The company's Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare, and consumer products to retailers, hospitals, and other healthcare providers.

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply